We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.85 | 0.80 | 0.90 | 0.85 | 0.85 | 0.85 | 119,308 | 07:36:40 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.49 | 1.54M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/8/2017 12:53 | It looks like the share overhang which has been depressing the shares has finally been absorbed. I expect even modest buying from here will propel the shares back up. | biggest bill | |
10/8/2017 12:49 | Someone has!!! | moormoney | |
10/8/2017 12:40 | Notice the bear posts dried up the last few days - you all been buying! | whl2 | |
09/8/2017 11:15 | 700k buy - explains the rise yesterday, not mine by the way :{ | whl2 | |
07/8/2017 09:32 | Flexton, keep your word and stop posting. | square root | |
06/8/2017 20:51 | Key facts - Packages start at $500 per treatment.Typically 6 to 12 treatments are recommended Data from randomized trials are conflicting, and many questions remain to be answered before we can routinely offer this treatment to patients. This treatment has been around and known about for ~5 Yrs Another deramp bites the dust | zebbo | |
04/8/2017 00:46 | I dont think a lot of people are listening Flexton. This is listed on aim i believe , no more than a casino. No one is really believes anything people say. This is just playing at a roulette wheel No one cares if you are right or wrong, so dont come back and admit if you are wrong.no need. Spin the wheel guys! | escapetohome | |
03/8/2017 23:24 | Good riddance flexton.... | zebbo | |
03/8/2017 16:21 | Flexton, I don't believe a word you say any more. I don't see any point in trying to communicate with somebody with your wonderful ability to rewrite the past. I have never filtered anybody before but you now have the distinction of being the first. Edit: I see that you have now rewritten some of your posts in the last few minutes in an attempt to paint yourself in a better light without bothering to make clear that you have edited those posts. So you really are rewriting the past. | biggest bill | |
03/8/2017 16:11 | Flexton, only ten minutes ago you claimed that you had correctly predicted that the share price here would go under 5p. This claim was made only 2 days ago. Are you having problems remembering what you wrote? | biggest bill | |
03/8/2017 16:05 | Flexton, your ability to rewrite history (at least in your own mind) is quite extraordinary. | biggest bill | |
03/8/2017 16:00 | Flexton, your first post on N4P was on 1/8/17 and you have certainly not made a correct prediction about the share price here. Your many subsequent posts here have been ridiculous to put it mildly. For somebody who claims to hold shares here (which I don't believe for a minute), your behaviour has been bizarre. | biggest bill | |
03/8/2017 15:39 | Papillon, with hindsight it's very easy to pick out someone's failed predictions and laugh at them. The problem is that I'm sure I could do it with some of your predictions and some of mine as well. | biggest bill | |
03/8/2017 15:09 | ZEBBO 31 May '17 - 22:14 - 136 of 516 1 0 Lets not talk about penny moves, next stop 20p min. End of year 50p if some positive news, certainly not out of the question >>>>> LOL. LOL. Your ramping didn't work, did it ZEBBO? Next stop was NOT 20p, but 5p. I should get a new crystal ball buddy; your present one is obviously well past it's sell by date! The amount of ramping that goes on on these advfn & lse bb's is absolutely mindblowing. | papillon |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions